Blog
About

6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury.

      Stem Cells (Dayton, Ohio)

      Acetylation, drug effects, Animals, Disease Progression, Gene Expression Regulation, Glomerulonephritis, drug therapy, etiology, metabolism, Glomerulosclerosis, Focal Segmental, Hematopoietic Stem Cells, Histone Deacetylase Inhibitors, Histones, Hydroxamic Acids, pharmacology, therapeutic use, Kidney, cytology, Mice, Mice, Inbred C57BL, Multipotent Stem Cells, Nephritis, Interstitial, prevention & control, Protein Processing, Post-Translational, Sheep, blood, Specific Pathogen-Free Organisms, Transcription Factors, biosynthesis, genetics

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Bone morphogenic protein (BMP)-7 is expressed in the adult kidney and reverses chronic renal injury when given exogenously. Here, we report that a histone deacetylase inhibitor, trichostatin A (TSA), attenuates chronic renal injury, in part, by augmenting the expression of BMP-7 in kidney side population (SP) cells. We induced accelerated nephrotoxic serum nephritis (NTN) in C57BL/6 mice and treated them with TSA for 3 weeks. Compared with vehicle-treated NTN mice, treatment with TSA prevented the progression of proteinuria, glomerulosclerosis, interstitial fibrosis, and loss of kidney SP cells. Basal gene expression of renoprotective factors such as BMP-7, vascular endothelial growth factor, and hepatocyte growth factor was significantly higher in kidney SP cells as compared with non-SP cells. Treatment with TSA significantly upregulated the expression of BMP-7 in SP cells but not in non-SP cells. Moreover, initiation of treatment with TSA after 3 weeks of NTN (for 3 weeks, until 6 weeks) partially but significantly reversed renal dysfunction. Our results indicate an important role of SP cells in the kidney as one of the possible generator cells of BMP-7 and TSA as a stimulator of the cells in reversing chronic renal disease. Disclosure of potential conflicts of interest is found at the end of this article.

          Related collections

          Author and article information

          Journal
          17641247
          10.1634/stemcells.2007-0049

          Comments

          Comment on this article